Dual-target, High-dose TMS for PD Patients With FOG

NCT05625386 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
64
Enrollment
OTHER
Sponsor class

Stopped The study was halted at the midpoint because the interim analysis demonstrated a large effect size of the DHT group compared with the SCT group (Cohen's d = 1.58).

Conditions

Interventions

Sponsor

Anhui Medical University